Evidence map›Paper›PMID 38046809›Full record

ArticleCanadian respiratory journal2023

Comparison of the Diagnostic Performance of Five Clinical Questionnaires for Chronic Obstructive Pulmonary Disease.

Alirio R Bastidas, Eduardo Tuta-Quintero, José S Arias, Diana Cufiño, Diana Moya, Daniel Martin, Faure Rodríguez, Carolina Aponte-Murcia, Doris M Pumarejo, Maria A Bejarano and 6 more

Open access · goldAbstract read
In one paragraph

Article in Canadian respiratory journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. A Two-Staged, Risk-Stratified Strategy Combining FEVRespirology (Carlton, Vic.) · 2025
    Observational
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Alirio R BastidasSchool of Medicine, Universidad de La Sabana, Chía, Colombia.ORCID 0000-0002-8873-9779
Eduardo Tuta-QuinteroSchool of Medicine, Universidad de La Sabana, Chía, Colombia.ORCID 0000-0002-7243-2238
José S AriasSchool of Medicine, Universidad de La Sabana, Chía, Colombia.
Diana CufiñoSchool of Medicine, Universidad de La Sabana, Chía, Colombia.
Diana MoyaSchool of Medicine, Universidad de La Sabana, Chía, Colombia.
Daniel MartinSchool of Medicine, Universidad de La Sabana, Chía, Colombia.
Faure RodríguezSchool of Medicine, Universidad de La Sabana, Chía, Colombia.
Carolina Aponte-MurciaClínica Universidad de La Sabana, Chía, Colombia.
Doris M PumarejoSchool of Medicine, Universidad de La Sabana, Chía, Colombia.
Maria A BejaranoSchool of Medicine, Universidad de La Sabana, Chía, Colombia.
Geraldine OspinaSchool of Medicine, Universidad de La Sabana, Chía, Colombia.
Lina M MoralesSchool of Medicine, Universidad de La Sabana, Chía, Colombia.
Adriana M PortellaSchool of Medicine, Universidad de La Sabana, Chía, Colombia.
Maria D BarragánSchool of Medicine, Universidad de La Sabana, Chía, Colombia.
Daniela A ÁlvarezSchool of Medicine, Universidad de La Sabana, Chía, Colombia.
José M HernándezSchool of Medicine, Universidad de La Sabana, Chía, Colombia.
Universidad de La Sabana · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Chronic obstructive pulmonary disease (COPD) remains one of the most prevalent pathologies in the world and is among the leading causes of mortality and morbidity, partially due to underdiagnosis. The use of clinical questionnaires to identify high-risk individuals to take them to further diagnostic procedures has emerged as a strategy to address this problem. Objective: To compare the performance of the COULD IT BE COPD, CDQ, COPD-PS, LFQ, and PUMA questionnaires for COPD diagnosis. Methods: A cross-sectional study was carried out on subjects who underwent spirometry in the third-level center. Data were collected between January 2015 and March 2020. Bivariate analysis was performed between the study variables and the presence of COPD. The area under the receiver operating characteristics curve (AUC-ROC), sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), positive likelihood ratio (LR+), and negative likelihood ratio (LR-) for each questionnaire were calculated. The AUC-ROCs were compared with the DeLong test, considering a Results: 681 subjects met the inclusion criteria and were taken to the final analysis. The prevalence of COPD was 27.5% (187/681). The mean age of the subjects was 65.9 years (SD ± 11.79); 46.3% (315/681) were female, and 83.6% (569/681) reported respiratory symptoms. Statistically significant relationship was found for COPD diagnosis with male sex, older age, respiratory symptoms, and exposure to wood smoke ( Conclusion: The CDQ, COPD-PS, LFQ, PUMA, and COULD IT BE COPD questionnaires have acceptable performance for the diagnosis of COPD together with low sensitivity and specificity. Therefore, its use must be complemented with other diagnostic tests or techniques such as pulmonary function tests.

Indexed as

Apoptosis Regulatory ProteinsPulmonary Disease, Chronic ObstructiveAgedCross-Sectional StudiesFemaleForced Expiratory VolumeHumansMaleSensitivity and SpecificitySpirometrySurveys and QuestionnairesApoptosis Regulatory Proteins

Identifiers

PMID38046809
PMCPMC10691892
OpenAlexW4388970889

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.